NCT00772070View on ClinicalTrials.gov

Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate Vaccine

PHASE2CompletedINTERVENTIONAL

Enrollment

173

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

August 31, 2003

Study Completion Date

May 31, 2004

Conditions

MeningitisMeningococcemiaNeisseria Meningitidis

Interventions

BIOLOGICAL

A/C/Y/W-135, Meningococcal Polysaccharide Vaccine (Menomune®)

0.05 mL, Subcutaneous

BIOLOGICAL

A/C/Y/W-135, Meningococcal Polysaccharide Vaccine (Menomune®)

0.05 mL, Subcutaneous

Trial Locations (8)

14620

Rochester

15241

Pittsburgh

18960

Sellersville

23501

Norfolk

63044

Bridgeton

72211

Little Rock

72401

Jonesboro

01801

Woburn

All Listed Sponsors

lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT00772070 - Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate Vaccine | Biotech Hunter | Biotech Hunter